Butterfly Network Inc - Class A risk profile
51 Elevated one input has moved against it
Measured 21 October 2026 from BFLY's filed statements. Recomputed nightly.
51 (Elevated), driven by Cash conversion at 100, over 7 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 59 | Elevated | Volatile | One-year price volatility — 125.0% |
| Operating pressure | 14 | Contained | Worsening | Costs outgrowing revenue — -5.3 percentage points |
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -0.26x |
| Leverage and coverage | 37 | Normal | Stable | Interest cover — -53.50x |
| Competitive position | 67 | Stretched | Stable | Operating-margin gap against peers — -92.2 percentage points |
| Concentration | 76 | Stretched | Stable | Geographic concentration — 6,294 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 33Johnson & Johnson 39Abbvie Inc 57Unitedhealth Group Inc 43Roche Holding AG 35Merck & Co Inc 35Novartis AG 29Novartis AG 31Astrazeneca plc 33Thermo Fisher Scientific Inc 44AMGEN Inc 47Gilead Sciences Inc 51
Financials, valuation and price history for Butterfly Network Inc - Class A